Healthcare Services

Human Chorionic Gonadotropin Market Future Outlook Showing Expansion Toward $1.51 Billion by 2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Human Chorionic Gonadotropin Market Over The 2026–2030 Period?

The human chorionic gonadotropin market size has experienced significant growth in recent years. It is anticipated to expand from $1.02 billion in 2025 to $1.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. This historical expansion can be attributed to various factors, including the increasing prevalence of infertility, the worldwide growth of fertility clinics, the long-standing clinical application of hCG in reproductive medicine, a rising awareness of hormonal imbalance treatments, and the availability of natural source hCG products.

The human chorionic gonadotropin market is projected to experience substantial expansion over the upcoming years. This market is set to reach $1.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. Several factors are expected to drive this growth during the forecast period, including the surging demand for assisted reproductive technologies, the wider acceptance of recombinant hormones, a heightened emphasis on precision fertility solutions, the broadening reach of online and retail pharmacy distribution channels, and increased funding for reproductive health research. Key developments anticipated during the forecast period encompass the augmented utilization of hCG in assisted reproductive treatments, an escalating need for hormonal therapies in addressing infertility, the increasing uptake of recombinant hCG products, the broadening scope of hCG applications for male hormonal disorders, and an intensified drive towards standardized and high-purity hormone formulations.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18638&type=smp

What Underlying Factors Are Accelerating The Growth Of The Human Chorionic Gonadotropin Market?

The human chorionic gonadotropin market is anticipated to experience growth driven by a rising rate of infertility. Infertility describes the inability to conceive after at least one year of consistent, unprotected sexual intercourse. The incidence of infertility is increasing due to the growing number of individuals and couples encountering conception challenges, stemming from factors like delayed childbearing, evolving lifestyles, environmental exposures, and various medical conditions. Human chorionic gonadotropin (hCG) is employed in infertility treatments to stimulate ovulation in women and support testosterone production in men, thereby assisting in egg release and enhancing fertility outcomes. For instance, in April 2023, the World Health Organization, a Switzerland-based intergovernmental organization, reported that around 17.5% of the adult population, or roughly one in every six people worldwide, was affected by infertility, underscoring the critical necessity for improved access to affordable, high-quality fertility care for those in need. Consequently, the increasing rate of infertility is a key driver for the expansion of the human chorionic gonadotropin market.

How Is The Human Chorionic Gonadotropin Market Segmented Across Key Categories?

The human chorionic gonadotropin market covered in this report is segmented –

1) By Technology: Natural Source Extraction, Recombinant Technology

2) By Therapeutic Area: Female Infertility Treatment, Oligospermic Treatment, Male Hypogonadism, Other Therapeutic Areas

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End User: Fertility Clinics, Research Institutions, Other End Users

Subsegments:

1) By Natural Source Extraction: Extraction From Pregnant Women’s Urine, Purified Urinary hCG (u-hCG) Formulations

2) By Recombinant Technology: Recombinant Hcg, Recombinant Hcg For Therapeutic Use, Recombinant Hcg For Diagnostic Applications

Who Are The Dominant Players Shaping The Human Chorionic Gonadotropin Market Landscape?

Major companies operating in the human chorionic gonadotropin market are Ferring Pharmaceuticals, Merck KGaA, Organon, IBSA Institut Biochimique, Teva Pharmaceutical Industries, Sandoz, Sun Pharmaceutical Industries, Cipla, Zydus Lifesciences, Lupin, Intas Pharmaceuticals, Hikma Pharmaceuticals, Aspen Pharmacare, Menarini Group, Bharat Serums and Vaccines, Serum Institute of India, LG Chem Life Sciences, Dong-A ST, Livzon Pharmaceutical Group, SciGen

Read the full human chorionic gonadotropin market report here:

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

Which Region Is Projected To Dominate The Human Chorionic Gonadotropin Market During The Forecast Period?

North America was the largest region in the human chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Human Chorionic Gonadotropin Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18638&type=smp

Browse Through More Reports Similar to the Global Human Chorionic Gonadotropin Market 2026, By The Business Research Company

Male Hypogonadism Global Market Report

https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

Gonadotropin Releasing Hormone Gnrh Agonist Global Market Report

https://www.thebusinessresearchcompany.com/report/gonadotropin-releasing-hormone-gnrh-agonist-global-market-report

Hormone Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795